Trial Profile
Pharmacokinetics of Levosimendan in Children With Acute Heart Failure
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Acute heart failure; Chronic heart failure
- Focus Pharmacokinetics
- Acronyms LevoCorKids
- 24 Feb 2020 This trial is Discontinued in Finland, according to European Clinical Trials Database record.
- 19 Aug 2019 Planned End Date changed from 1 Nov 2018 to 1 Sep 2019.
- 19 Aug 2019 Planned primary completion date changed from 1 Nov 2016 to 1 Sep 2019.